In a recent study published in the journal Eurosurveillance, researchers investigated the unusual rise in emergency department (ED) visits for pneumonia among children aged 5–14 years in England since November 2023.
Their findings indicate that this increase, which persisted into early summer 2024, was primarily driven by the bacteria Mycoplasma pneumoniae (MP), even as other seasonal respiratory infections decreased.
Background
Respiratory infections during the winter often burden healthcare services in the UK. The UK Health Security Agency (UKHSA) manages a surveillance program that tracks and reports respiratory illnesses yearly to help understand and manage their impact.
Recently, an unusual rise in pneumonia cases among children between the ages of 5 and 14 was detected through the program, leading to an investigation to understand what was causing this unexpected increase.
About the study
The UKHSA’s program monitors respiratory infections through various systems, including lab reports, general practice data, and real-time tracking of ED visits.
The surveillance program includes data from primary care physicians, laboratory reports, hospital admissions, ED attendance, and telehealth calls, monitoring a range of respiratory indicators from the milder common colds, which are self-limiting, to more severe illnesses like pneumonia.
This monitoring helps identify mild and severe respiratory illnesses and their effects on the healthcare system, particularly during the high-demand winter months.
Findings
Beginning in November 2023, the number of children between the ages of 5 and 14 visiting EDs for pneumonia began to rise above historical expectations, as observed through the UKHSA’s syndromic surveillance system.
This elevated activity continued through December 2023 and did not follow the typical seasonal decline in January 2024. Instead, the higher-than-expected number of pneumonia-related ED visits persisted between February and July 2024.
During this period, 2,532 pneumonia-related ED visits were recorded in this age group, which, while lower than the 45,003 cases reported in individuals aged 15 years and older, was still significantly higher than in previous years.
For context, the average number of visits during the same period of 2019-20 and 2022-23 for this age group were, respectively, 607 and 818, highlighting a notable surge in 2024.
Further analysis using data from the Emergency Care Dataset (ECDS) and linked laboratory reports confirmed that, between November 2022 and May 2024, there were 14,096 pneumonia-related ED attendances, with 2,334 of these linked to positive microbiology results.
Among the pathogens identified, Respiratory Syncytial Virus (RSV) accounted for 16.6% of cases, influenza A virus for 9.8%, and MP for 9.3%.
While RSV and influenza followed their usual seasonal patterns, MP showed a marked increase in early 2024, particularly among children aged 5–14, where it was found in 32.2% of pneumonia cases.
Additionally, increasing trends in MP infections were observed in children between the ages of 1 and 4, suggesting a broader impact across younger age groups.
Conclusions
The study found a persistent increase in emergency department visits for pneumonia among children between the ages of 5 and 14, primarily due to an unusual rise in MP infections during the winter of 2023-24, the first significant MP epidemic after the coronavirus disease 2019 (COVID-19) pandemic.
MP is a common cause of bacterial pneumonia among school-going children, and while infections are usually mild, some can lead to severe illness.
The study highlights the importance of real-time syndromic surveillance, which enabled early detection of this trend and timely public health responses. England’s 2023-24 MP epidemic was part of a global increase in MP cases, but the unusually prolonged season was notable.
The reasons for this prolonged activity remain unclear, but it might be linked to changes in disease transmission patterns due to pandemic-related public health measures.
In conclusion, the study underscores the value of the UK Health Security Agency’s (UKHSA) comprehensive respiratory surveillance program, which includes real-time syndromic surveillance to detect and quickly investigate unusual patterns of illness.
The findings also indicate the need for further research to better understand MP and its impact on public health.
- Persistent elevation in incidence of pneumonia in children in England, 2023/24. Todkill, D., Lamagni, T., Pebody, R., Ramsay, M., Woolham, D., Demirjian, A., Salzmann, A., Chand, M., Hughes, H.E., Bennett, C., Hope, R., Watson, C.H., Brown, C.S., Elliot, A.J. Eurosurveillance (2024). DOI: 10.2807/1560-7917.ES.2024.29.32.2400485, https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.32.2400485
News
NIH Scientists Discover Gene Responsible for Rare Eye Disease
Findings supported by the NIH pave the way for the development of genetic testing, clinical trials, and therapies. Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a gene linked to certain [...]
Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s agitation medications. A study conducted by researchers from Johns Hopkins University School of Medicine and Tufts University School of Medicine found that a pill form [...]
The Future of Rare Disease Treatment with Precision Medicine
Understanding rare diseases Rare diseases affect less than 5 people out of 10,000. However, this still amounts to about 7% of the world’s population, with over 10,000 such conditions. Almost all are genetic in [...]
Doctors issue warning for upcoming ‘tripledemic
The term ‘tripledemic’ has hit headlines this week as the NHS begins its Covid and fluvaccine roll-out for vulnerable adults. As the cold weather sets in, many of us have experienced a decline in health, and this may [...]
The FDA approved a gel that can stop bleeding from wounds in seconds
Aug 15 (Reuters) - The U.S. Food and Drug Administration has cleared Cresilon's gel to quickly control bleeding, the privately held company said on Thursday, potentially giving emergency medical technicians and combat medics a [...]
High levels of microplastics found in prostate tumors, possibly linked to take-out food
The presence of microplastics in prostate tumors points to potential health risks, and researchers are calling for urgent studies to explore how take-out food may be driving this exposure. In a recent study published [...]
AI outperforms radiologists in brain tumor diagnosis
As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise. In the field of radiology, where a correct diagnosis is crucial to ensure [...]
Breakthrough Study Reveals Molecular Clues to Dementia Origins
Work could lead to the discovery of new therapeutic targets. For the first time, researchers have identified “molecular markers” linked to degeneration—detectable changes in cells and their gene-regulating networks—that are common across several types [...]
Better than blood tests? Nanoparticle potential found for assessing kidneys
In a study published July 29 in Advanced Materials, University of Texas at Dallas researchers found that X-rays of the kidneys using gold nanoparticles as a contrast agent might be more accurate in detecting kidney [...]
Greener nanomaterials could transform how our everyday stuff is made
Tiny nanoparticles are at the forefront of materials science—with special properties that make them great at absorbing light in solar panels, cleaning wastewater, and delivering drugs precisely. Some nanoparticles take the form of sheets or fibers. But nanomaterials all [...]
AI could predict breast cancer risk via ‘zombie cells’
Women worldwide could see better treatment with new AI technology, which enables better detection of damaged cells and more precisely predicts the risk of getting breast cancer, shows new research from the [...]
Through the eyes of a cat – biomimicry of feline eyes may revolutionize robotic vision
In a recent study published in the journal Science Advances, researchers leveraged crucial aspects of feline eyes, particularly their tapetum lucidum and vertically elongated pupils (VP), to develop a monocular artificial vision system capable of [...]
New Alzheimer’s Therapy Shows Remarkable Results in Animal Trials
A study from TUM demonstrates a promising therapeutic approach. Researchers at the Technical University of Munich (TUM) have made promising advances in preventing Alzheimer’s by developing a new therapeutic strategy. Their approach focuses on targeting the amyloid beta [...]
Rewriting Cancer’s Blueprint: New Study Challenges Old Theories
A new study argues for a revised clonal evolution model of cancer, incorporating genetic and non-genetic factors to improve understanding and treatment. Like all living organisms, cancer cells are driven by the fundamental need [...]
Microplastics Everywhere: Experts Demand Worldwide Treaty Before It’s Too Late
A new report calls for global action on plastic pollution, urging reductions in plastic production and microplastic emissions. Researchers stress the importance of addressing plastic pollution through both scientific and social science perspectives. A [...]
Blood tests could soon predict your risk of Alzheimer’s
Scientists are closing in on biomarkers that reflect the progression of Alzheimer’s disease and could improve treatments. Like many Alzheimer’s researchers, neurologist Randall Bateman is not prone to effusiveness, having endured disappointments in his [...]
